trending Market Intelligence /marketintelligence/en/news-insights/trending/GPsf7WpLRjiIx5irtG8l0Q2 content esgSubNav
In This List

Canada's Bellus Health raises additional $9.4M from IPO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Canada's Bellus Health raises additional $9.4M from IPO

BELLUS Health Inc. said it raised an additional $9.4 million after underwriters partially exercised their overallotment option in the company's IPO.

Canada's Bellus Health sold an additional 1,320,296 common shares at $7.10 apiece to the underwriters. Jefferies, Cowen and Guggenheim Securities acted as joint book-running managers, Baird as lead manager and Bloom Burton Securities as co-manager for the offering.

Gross proceeds from the IPO now stand at about $79.4 million and will help the company in research and development activities, among other things.

The biotechnology company develops therapies to treat chronic cough and other hypersensitization-related disorders.